Organisation paid for research Program year 2024 Source: CMS Open Payments

Reliable Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$553,891

21 payments

Through program year 2024, Reliable Clinical Research, LLC is reported as receiving $553,891 in research payments, across 21 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$7,065	5
2023	Research	$22,702	1
2022	Research	$68,886	2
2021	Research	$450,166	10
2019	Research	$5,073	3

Breakdown

Who paid Research payments · program years 2019–2024

Sagent Pharmaceuticals, Inc. $291,642 8 payments
Amgen Inc. $250,112 5 payments
Sanofi US Services Inc. $7,065 5 payments
Akebia Therapeutics Inc $5,073 3 payments

Studies the money was for Research payments · program years 2019–2024

CAMELOT Trial (Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID19) $291,642 8 payments
US Pt Satisfaction $250,112 5 payments
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma $7,065 5 payments
Akb-6548-Ci-0015 $5,073 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.